le dimanche 22 juillet 2018, à 18:32. Posté
par Darrel
Can you put it on the scales, please? http://raicesdeeuropa.com/hnamedicalcom-04ae.pdf#folly hnamedical.com The company said the U.S. Food and Drug Administrationgranted fast-track status to its lead experimental drugganetespib as a treatment for non-small cell lung cancer. A fast-track designation expedites regulatoryreview of drugs that aim to treat serious diseases and fillunmet medical needs.